ARS Pharmaceuticals, Inc.SPRYNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$12.98M
↑ 169% above average
Average (6y)
$-18.93M
Historical baseline
Range
High:$12.98M
Low:$-59.44M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $12.98M | +121.8% |
| 2023 | $-59.44M | -47.6% |
| 2022 | $-40.28M | -128.6% |
| 2021 | $-17.62M | -316.0% |
| 2020 | $8.15M | +142.9% |
| 2019 | $-18.99M | -9.6% |
| 2018 | $-17.32M | - |